Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma

Table 1 Baseline information of 4 cases

Case	Gender	Age at RCC	RCC stage	RCC’s Treatment	Interval time (months)	GBM’s treatment	Age at spGBM	Status	Survival time (months)
1	Male	76	T1N0M0	Surgery	47.5	Stupp regimen	80	Dead	11.2
2	Female	66	T1N0M0	Surgery	23.0	Stupp regimen	68	Dead	3.2
3	Female	62	T1N0M0	Surgery + IL-2	92.9	Stupp regimen	70	Dead	15.1
4	Male	49	T1N0M0	Surgery + IL-2	53.9	Stupp regimen^a	53	Dead	14.2

^astandard radiotherapy plus concomitant daily temozolomide, followed by adjuvant temozolomide

ISSN: 1471-2407